ADPT

ADPT

USD

Adaptive Biotechnologies Corporation Common Stock

$17.330+0.570 (3.401%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$16.760

High

$17.510

Low

$16.510

Volume

1.88M

Company Fundamentals

Market Cap

2.6B

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

1.97M

Exchange

NMS

Currency

USD

52-Week Range

Low $4.27Current $17.330High $17.886

Related News

Analyst Upgrades

BTIG Maintains Buy on Adaptive Biotechnologies, Raises Price Target to $19

BTIG analyst Mark Massaro maintains Adaptive Biotechnologies with a Buy and raises the price target from $14 to $19.

View more
BTIG Maintains Buy on Adaptive Biotechnologies, Raises Price Target to $19
Analyst Upgrades

JP Morgan Maintains Overweight on Adaptive Biotechnologies, Raises Price Target to $17

JP Morgan analyst Sebastian Sandler maintains Adaptive Biotechnologies with a Overweight and raises the price target from $14 to $17.

View more
JP Morgan Maintains Overweight on Adaptive Biotechnologies, Raises Price Target to $17